World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-IPR-15006124
Date of registration: 2015-03-17
Prospective Registration: No
Primary sponsor: Third Military Medical University
Public title: Effect of supplementation of proanthocyanidins combined with vitamin C and E on type 2 diabetes
Scientific title: Effect of supplementation of proanthocyanidins combined with vitamin C and E on type 2 diabetes
Date of first enrolment: 2015-03-16
Target sample size: Control group:27;Proanthocyanidins intervention group:27;Vc+Ve group:27;Proanthocyanidins+Vc+Ve group:27;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10613
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Pilot study
Countries of recruitment
China
Contacts
Name: Yu Li   
Address:  30 Gaotanyan Street, Shapingba district, Chongqing
Telephone: +86 18580498626
Email: gyulilove.happy@163.com
Affiliation:  Third Military Medical University
Name: Mi Mantian   
Address:  30 Gaotanyan Street, Shapingba district, Chongqing
Telephone: +86 13508305561
Email: mimt@sina.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: According to anyone of the diagnostic criteria recommended by the American Diabetes Association in 2010, type 2 diabetes mellitus was diagnosed as:
1. Glycated hemoglobin higher than 6.5%*, or
2. Fasting plasma glucose higher than 7.0 mmol/L. Fasting is defined as at least 8h no calorie intake*, or
3. 2h-postgrandial glucose >=11.1 mmol/L in OGTT test*, or
4. With the typical symptoms of patients with hyperglycemia or hyperglycemia crisis, random blood glucose >=11.1 mmol/l.
(* In the absence of clear hyperglycemia, criteria 1-3 should be confirmed by repeat test)
And subjects also meet the following criteria:age between 40 to 65 years,diagnosed with type 2 diabetes at least for half a year, meet all ethical requirements and sign the informed consent form, live in Chongqing in the next 4 months and vist to the hospital conveniently.

Exclusion criteria: 1. Hyperthyroidism;
2. A short life expectancy with diseases such as malignant tumor;
3. serious complications of diabetes;
4. Severe chronic diseases or severe hepatic and renal dysfunction;
5. A history of severe hypoglycemia;
6. Patients with poor compliance.


Age minimum: 40
Age maximum: 65
Gender: Both
Health Condition(s) or Problem(s) studied
type 2 diabetes
Intervention(s)
Control group:Placebo;Proanthocyanidins intervention group:Proanthocyanidins;Vc+Ve group:Vc+Ve;Proanthocyanidins+Vc+Ve group:????+???C+???E;
Primary Outcome(s)
Fasting plasma glucose;
Secondary Outcome(s)
triglycerides;Total cholesterol;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;Insulin;Glycated hemoglobin;
Secondary ID(s)
Source(s) of Monetary Support
By-health Co.,Ltd
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history